entertainment -WSS

entertainment

author：leisure time 2025-09-30 16:24:02 - browse：84

STAT's Megan Molteni speaks with Feng Zhang in New York on March 21, 2024 — Scientist Feng Zhang, right, is interviewed by reporter Megan Molteni at STAT's Breakthrough Summit East. STAT

When the first biotech companies emerged to capitalize on the revolutionary genome-editing technology CRISPR, Editas Medicine seemed like the pacesetter. It locked up some of the crucial IP, and had behind it the pioneering scientist Feng Zhang of the Broad Institute as one of its founders.

But now, a decade later, Editas is seen as lagging behind its peers. CRISPR Therapeutics, in partnership with Vertex Pharmaceuticals, won the race to get the first CRISPR-based medicine across the finish line. Intellia Therapeutics was the first to show that CRISPR editing could be performed inside the body. Editas, meanwhile, has seen a revolving door among its executives.

So what happened?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： The Readout: Lenmeldy, GLP

focus

WSS

The UK government moves asylum

Mississippi candidates for statewide offices square off in party primaries

Biden will tout long

Why workplace violence is so common in health care

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

'The Exorcist' director William Friedkin dead at 87

focus

entertainment

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Drug repurposing or repositioning? The language matters

Vertex Pharmaceuticals may move headquarters in Boston

DIEP, the 'gold standard' of breast reconstruction, is under threat

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Jerome Adams on the need for new antivirals for Covid

Will generative AI in health care meet the fate of IBM's Dr. Watson?

At least 13 dead in Texas as scorching temps continue

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

leisure time

In medicine, common shorthands can shortchange care

The Readout: Lenmeldy, GLP

Will generative AI in health care meet the fate of IBM's Dr. Watson?

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Covid vaccine financial winners and losers, from Pfizer to Novavax

Democratic lawmaker calls for 'well

focus

focus

Wikipedia

hotspot